Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NUVB · against 446 other Healthcare companies of similar size
Ranked #319 of 447 · scores higher than 29% of peers · safety percentile 33
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)39 peers with a safety percentile of 30–39, including NUVB · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NUVB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 424 reported | 1.64× | 0.21× | 9% | 33% | |
| BetaLower is better · 419 reported | 1.62 | 0.52 | 9% | 33% | |
| Current ratioHigher is better · 433 reported | 8.37× | 2.79× | 84% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 1.0B USD | 99 | 35 | |
| 315 | 51.3B ZAR (≈$2.8B) | 34 | 73 | |
| 316 | 6.3B CNY (≈$881M) | 34 | 44 | |
| 317 | 15.6B SEK (≈$1.6B) | 33 | 42 | |
| 318 | 15.3B CNY (≈$2.1B) | 33 | 57 | |
| 319 | 1.6B USD | 33 | 38 | |
| 320 | 914M USD | 32 | 81 | |
| 321 | 1.7B USD | 32 | 30 | |
| 322 | 17.9B ZAR (≈$986M) | 32 | 62 | |
| 323 | 1.3B USD | 31 | 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score